Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Recruiting2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06080191Phase 1Recruiting
Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL
B-cell Acute Lymphoblastic Leukemia
PrincipalinvestigatorStart date: 2024-04-28
NCT06064903Phase 1/2Recruiting
CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL
T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
PrincipalinvestigatorStart date: 2024-04-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Director Department of Hematology/Oncology and Cell and Gene Therapy

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06080191Phase 1PrincipalInvestigator

Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL

B-cell Acute Lymphoblastic Leukemia
Recruiting
NCT06064903Phase 1/2PrincipalInvestigator

CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Recruiting

All 2 trials loaded